Jochim, Angela
Meindl, Tobias
Mantel, Tobias
Zwirner, Silke
Zech, Michael
Castrop, Florian
Haslinger, Bernhard
Article History
Received: 2 April 2019
Revised: 25 April 2019
Accepted: 26 April 2019
First Online: 2 May 2019
Compliance with ethical standards
:
: A Jochim has received travel grants from Ipsen Pharma GmbH, Merz Pharmaceuticals GmbH, Pharm-Allergan GmbH, Boston Scientific, Bayer Health and Universitätsklinikum Würzburg as well as speaker honoraria from Pharm-Allergan GmbH. T. Meindl has received travel grants from Ipsen Pharma GmbH, Merz Pharmaceuticals GmbH, Pharm-Allergan GmbH and Boston Scientific Medizintechnik. GmbH. T. Mantel has received travel grants from Bayer Vital GmbH. S. Zwirner has no conflicts of interest. M. Zech is supported by an internal research program at Helmholtz Center Munich, Germany (“Physician Scientists for Groundbreaking Projects”), has received travel expenses from Pharm-Allergan GmbH, and has received speaker honoraria from Bayer Vital GmbH. F. Castrop has no conflicts of interest. B. Haslinger has received research support from the German Research Foundation (DFG), Pharm-Allergan GmbH and Ipsen Pharma GmbH, has received speaker honoraria from Pharm-Allergan GmbH and Bayer Health Care Pharmaceuticals and has received travel grants from Ipsen Pharma GmbH.
: The study has been approved by the local ethics review board. All patients whose data were not only acquired retrospectively, but also recorded prospectively, gave their written informed consent before entering the prospective phase of the study.